Telomir Pharmaceuticals (TELO) EBITDA (2023 - 2025)
Telomir Pharmaceuticals (TELO) EBITDA from Mar 31, 2023 to Dec 31, 2025. The TTM Telomir Pharmaceuticals (TELO) EBITDA is -$10M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Telomir Pharmaceuticals (TELO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.67% |
| All Time TTM | -14.26% |
Annual EBITDA change of Telomir Pharmaceuticals (TELO)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$10M | -14.60% |
| 2024 | -$12M | +6.65% |
| 2023 | -$11M | +1244.71% |
| 2022 | -$850K | N/A |